Angles-Cano E - Search Results

1

Acquired protein S deficiency with primary antiphospholipid syndrome and recurrent thrombotic events: report of a case.

Salazar-Paramo M, Orozco-Barocio G, Angles-Cano E, Garcia-De La Torre I. Salazar-Paramo M, et al. Rev Rhum Engl Ed. 1995 Dec;62(11):810-11. Rev Rhum Engl Ed. 1995. PMID: 8869229 No abstract available.

2

Antibodies to fibrin-bound tissue-type plasminogen activator in systemic lupus erythematosus are associated with Raynaud's phenomenon and thrombosis.

Salazar-Paramo M, Garcia de la Torre I, Fritzler MJ, Loyau S, Anglés-Cano E. Salazar-Paramo M, et al. Lupus. 1996 Aug;5(4):275-8. doi: 10.1177/096120339600500406. Lupus. 1996. PMID: 8869898

3

Antibodies to fibrin bound tissue type plasminogen activator in systemic sclerosis.

Fritzler MJ, Hart DA, Wilson D, García-De La Torre I, Salazar-Páramo M, Vázquez-Del Mercado M, Senécal JL, Loyau S, Anglés-Cano E. Fritzler MJ, et al. J Rheumatol. 1995 Sep;22(9):1688-93. J Rheumatol. 1995. PMID: 8523346

4

Advances in autoantibodies in SLE.

von Mühlen CA, Chan EK, Anglés-Cano E, Mamula MJ, Garcia-De La Torre I, Fritzler MJ. von Mühlen CA, et al. Lupus. 1998;7(8):507-14. doi: 10.1191/096120398678920613. Lupus. 1998. PMID: 9863891 Review. No abstract available.

5

Antibodies to tissue-type plasminogen activator in plasma from patients with primary antiphospholipid syndrome.

Cugno M, Dominguez M, Cabibbe M, Bisiani G, Galli M, Angles-Cano E, Agostoni A. Cugno M, et al. Br J Haematol. 2000 Mar;108(4):871-5. doi: 10.1046/j.1365-2141.2000.01948.x. Br J Haematol. 2000. PMID: 10792298 Free article.

6

Molecular assembly of plasminogen and tissue-type plasminogen activator on an evolving fibrin surface.

Fleury V, Loyau S, Lijnen HR, Nieuwenhuizen W, Anglés-Cano E. Fleury V, et al. Eur J Biochem. 1993 Sep 1;216(2):549-56. doi: 10.1111/j.1432-1033.1993.tb18173.x. Eur J Biochem. 1993. PMID: 8375393 Free article.

7

Familial association of high levels of histidine-rich glycoprotein and plasminogen activator inhibitor-1 with venous thromboembolism.

Angles-Cano E, Gris JC, Loyau S, Schved JF. Angles-Cano E, et al. J Lab Clin Med. 1993 May;121(5):646-53. J Lab Clin Med. 1993. PMID: 8478593

8

Primary pulmonary hypertension, tissue plasminogen activator antibodies, and HLA-DQ7.

Morse JH, Barst RJ, Fotino M, Zhang Y, Flaster E, Gharavi AE, Fritzler MJ, Dominguez M, Angles-Cano E. Morse JH, et al. Am J Respir Crit Care Med. 1997 Jan;155(1):274-8. doi: 10.1164/ajrccm.155.1.9001324. Am J Respir Crit Care Med. 1997. PMID: 9001324

9

Does apolipoprotein(a) heterogeneity influence lipoprotein(a) effects on fibrinolysis?

Hervio L, Chapman MJ, Thillet J, Loyau S, Anglés-Cano E. Hervio L, et al. Blood. 1993 Jul 15;82(2):392-7. Blood. 1993. PMID: 8329699 Free article.

10

Kringles of the plasminogen--prothrombin gene family share conformational epitopes with recombinant apolipoprotein (a): specificity of the fibrin-binding site.

Dominguez M, Rojas G, Loyau S, Bazurco M, Sorell L, Anglés-Cano E. Dominguez M, et al. Biochim Biophys Acta. 2001 Jul 9;1548(1):72-80. doi: 10.1016/s0167-4838(01)00215-1. Biochim Biophys Acta. 2001. PMID: 11451440

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

148 results

Search Page

Filters